Hanmi Pharm. Co., Ltd. (KRX:128940)

Hanmi Pharm. Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	192,278	54,980	147,329	209,225	146,157
Short-Term Investments	917.66	109,736	89,408	2,510	1,874
Trading Asset Securities	-	90,466	-	-	-
Cash & Short-Term Investments	193,195	255,183	236,736	211,734	148,032
Cash Growth	-24.29%	7.79%	11.81%	43.03%	36.95%
Accounts Receivable	238,253	168,139	178,357	217,428	144,395
Other Receivables	517.98	9,079	1,703	5,180	4,825
Receivables	238,771	177,219	180,060	222,609	149,220
Inventory	300,926	288,814	266,185	250,189	308,538
Prepaid Expenses	1,381	865.96	4,595	10,511	739.04
Other Current Assets	12,033	8,543	6,581	8,466	7,844
Total Current Assets	746,306	730,624	694,158	703,509	614,373
Property, Plant & Equipment	822,496	860,242	917,982	957,218	1,000,040
Long-Term Investments	147,505	29,942	57,424	38,090	43,994
Other Intangible Assets	45,427	46,271	48,007	48,708	47,561
Long-Term Accounts Receivable	10,095	17,372	5,927	9,964	6,218
Long-Term Deferred Tax Assets	145,599	127,993	89,902	91,856	89,986
Long-Term Deferred Charges	48,709	34,774	36,580	31,461	25,325
Other Long-Term Assets	44,213	51,451	74,606	55,922	54,529
Total Assets	2,020,840	1,898,668	1,924,586	1,936,729	1,882,027
Accounts Payable	38,599	45,180	39,710	42,833	32,214
Accrued Expenses	13,487	16,660	14,389	11,103	11,364
Short-Term Debt	370,600	336,100	369,100	255,900	238,100
Current Portion of Long-Term Debt	31,237	145,351	80,364	144,125	161,723
Current Portion of Leases	2,916	2,325	3,043	55,141	1,945
Current Income Taxes Payable	26,855	6,088	10,677	13,463	611.44
Other Current Liabilities	199,063	153,059	159,465	126,373	87,493
Total Current Liabilities	682,759	704,763	676,748	648,938	533,451
Long-Term Debt	85,862	82,028	217,330	290,619	388,962
Long-Term Leases	6,071	7,063	8,486	10,481	11,457
Long-Term Deferred Tax Liabilities	-	-	-	-	452.18
Other Long-Term Liabilities	5,397	4,603	12,795	49,405	99,691
Total Liabilities	780,089	798,458	915,359	1,008,469	1,050,137
Common Stock	32,027	31,405	30,795	30,196	29,608
Additional Paid-In Capital	411,343	411,965	412,575	413,175	413,763
Retained Earnings	680,888	581,979	452,297	396,916	334,117
Treasury Stock	-43,327	-40,047	-36,976	-33,142	-28,268
Comprehensive Income & Other	3,962	-29,860	13,174	-4,230	-19,231
Total Common Equity	1,084,893	955,442	871,866	802,914	729,987
Minority Interest	155,858	144,768	137,361	125,346	101,902
Shareholders' Equity	1,240,752	1,100,211	1,009,227	928,259	831,889
Total Liabilities & Equity	2,020,840	1,898,668	1,924,586	1,936,729	1,882,027
Total Debt	496,687	572,867	678,323	756,267	802,187
Net Cash (Debt)	-303,492	-317,685	-441,586	-544,532	-654,156
Net Cash Per Share	-23933.19	-25031.60	-34761.50	-42813.87	-51375.61
Filing Date Shares Outstanding	12.68	12.44	12.45	12.47	12.48
Total Common Shares Outstanding	12.68	12.69	12.7	12.72	12.73
Working Capital	63,548	25,861	17,410	54,571	80,922
Book Value Per Share	85557.97	75287.83	68636.66	63132.10	57333.59
Tangible Book Value	1,039,466	909,172	823,858	754,205	682,427
Tangible Book Value Per Share	81975.46	71641.74	64857.35	59302.24	53598.14
Land	131,866	131,788	131,280	131,256	129,166
Buildings	487,211	472,771	468,815	461,796	442,561
Machinery	875,653	838,165	837,205	792,572	738,355
Construction In Progress	13,146	14,815	6,206	69,731	111,646

Updated Feb 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.